Successful Exhibition for HUBER CHINA at CPhI in Shanghai
HUBER presents a range of new products and developments at CPhI in Shanghai
HUBER presents a range of new products and developments at CPhI in Shanghai
VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science
A breakthrough approach that overcomes scale-up and consistency challenges in microsphere production
Collaboration between UpNano and Husun Technologies brings 2PP 3D-printing to one of the world’s largest technology markets
A closer look at the markers that help distinguish HLH, CRS, and other cytokine storm syndromes
In this guest editorial discover what remains in our arsenal to combat antibiotic resistance, and how HORIBA Medical is advancing responsible prescribing to protect patient outcomes
From sepsis to syndromic panels, this SelectScience forum discussed how molecular diagnostics is setting new standards for accuracy, efficiency, and impact
In this guest editorial from the Clinical and Laboratory Standards Institute (CLSI), explore FDA clearance pathways and how CLSI standards can help expedite regulatory approval
Acquisition to include Red One™ solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control
The timesaving Lyovapor™ L-210 sets new efficiency standards while maintaining reliable and stable cooling performance
Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients
Advancing clinical pharmacokinetic prediction beyond non-human primate models